Developers-Doctor-patients: the artificial intelligence’s trifecta https://www.nature.com/articles/s41391-023-00718-7

Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression https://www.nature.com/articles/s41598-023-42711-z

Evolution of structural rearrangements in prostate cancer intracranial metastases https://www.nature.com/articles/s41698-023-00435-3

Changes in the gut microbial profile during long-term androgen deprivation therapy for prostate cancer https://www.nature.com/articles/s41391-023-00723-w

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy https://www.nature.com/articles/s42003-023-05289-w